An experimental pain medicine met the primary goal of a late-stage clinical trial, the drugs maker said Tuesday, setting the stage for it to seek approval from the US Food and Drug Administration thi… [read more]
An experimental pain medicine met the primary goal of a late-stage clinical trial, the drugs maker said Tuesday, setting the stage for it to seek approval from the US Food and Drug Administration thi… [read more]